# AO GENERIUM

Organization · id `cardio:org-ao-generium` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=AO+GENERIUM>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: AO GENERIUM
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: Study of Efficacy and Safety of GNR-060 vs Metalyse in Patients With ST Elevation Myocardial Infarction (`cardio:ct-nct05601999`)
- Sponsors: Efficacy and Safety Study of Proposed Biosimilar Product Reveliza vs Actilise in Patients With ST-segment Elevation Myocardial Infarction (`cardio:ct-nct07146360`)
- Sponsors: Reperfusion Approach in Predicted In-hospital Delay for Primary PCI in STEMI (`cardio:ct-nct07641231`)

## Provenance

Content hash: c3f1b4b2e039625cf880e882040c6f1468ad779c77374c418233387f97324bdc
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
